• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Uncommon efforts for an uncommon tumor: the case for development of newer systemic therapies for advanced thymic epithelial tumors.

作者信息

Achhal El Kadmiri Mohammed Amine, Rajan Arun

机构信息

Thoracic and Gastrointestinal Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

Mediastinum. 2018 Mar;2. doi: 10.21037/med.2018.03.04. Epub 2018 Mar 13.

DOI:10.21037/med.2018.03.04
PMID:30175322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6117157/
Abstract
摘要

相似文献

1
Uncommon efforts for an uncommon tumor: the case for development of newer systemic therapies for advanced thymic epithelial tumors.为罕见肿瘤付出非凡努力：开发晚期胸腺上皮肿瘤新型全身治疗方法的理由
Mediastinum. 2018 Mar;2. doi: 10.21037/med.2018.03.04. Epub 2018 Mar 13.
2
Current Treatment Approaches for Thymic Epithelial Tumors.胸腺上皮肿瘤的当前治疗方法
Life (Basel). 2023 May 12;13(5):1170. doi: 10.3390/life13051170.
3
Single-Cell Sequencing Illuminates Thymic Development: An Updated Framework for Understanding Thymic Epithelial Tumors.单细胞测序揭示胸腺发育：理解胸腺上皮肿瘤的更新框架。
Oncologist. 2024 Jun 3;29(6):473-483. doi: 10.1093/oncolo/oyae046.
4
Impact of PD-L1, transforming growth factor-β expression and tumor-infiltrating CD8 T cells on clinical outcome of patients with advanced thymic epithelial tumors.PD-L1、转化生长因子-β表达和肿瘤浸润 CD8 T 细胞对晚期胸腺癌患者临床结局的影响。
Thorac Cancer. 2018 Nov;9(11):1341-1353. doi: 10.1111/1759-7714.12826. Epub 2018 Aug 31.
5
Emerging treatment options for patients with recurrent advanced thymic epithelial tumors.复发晚期胸腺上皮肿瘤患者的新兴治疗选择
Onco Targets Ther. 2012;5:177-84. doi: 10.2147/OTT.S23267. Epub 2012 Sep 7.
6
Narrative review of indication and management of induction therapy for thymic epithelial tumors.胸腺上皮肿瘤诱导治疗的适应证与管理的叙述性综述
Mediastinum. 2024 May 31;8:44. doi: 10.21037/med-23-30. eCollection 2024.
7
Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers.274 例胸腺瘤的全面基因组分析揭示了致癌途径和预测性生物标志物。
Oncologist. 2022 Nov 3;27(11):919-929. doi: 10.1093/oncolo/oyac115.
8
Update on thymic epithelial tumors: a narrative review.胸腺上皮肿瘤的最新进展：一篇叙述性综述
Mediastinum. 2024 Apr 26;8:33. doi: 10.21037/med-23-47. eCollection 2024.
9
Methylation and expression profiles of MGMT gene in thymic epithelial tumors.MGMT 基因在胸腺瘤中的甲基化和表达谱。
Lung Cancer. 2014 Feb;83(2):279-87. doi: 10.1016/j.lungcan.2013.12.004. Epub 2013 Dec 21.
10
Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort.晚期胸腺癌的系统治疗：来自 RYTHMIC 前瞻性队列研究的见解。
J Thorac Oncol. 2018 Nov;13(11):1762-1770. doi: 10.1016/j.jtho.2018.08.005. Epub 2018 Aug 21.

本文引用的文献

1
Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.曾接受顺铂为基础化疗的胸腺瘤和胸腺癌患者中依维莫司的 II 期研究。
J Clin Oncol. 2018 Feb 1;36(4):342-349. doi: 10.1200/JCO.2017.74.4078. Epub 2017 Dec 14.
2
The genomic and epigenomic landscape in thymic carcinoma.胸腺癌的基因组和表观基因组格局
Carcinogenesis. 2017 Oct 26;38(11):1084-1091. doi: 10.1093/carcin/bgx094.
3
Novel Agents in the Treatment of Thymic Malignancies.胸腺恶性肿瘤治疗中的新型药物
Curr Treat Options Oncol. 2017 Aug 10;18(9):52. doi: 10.1007/s11864-017-0495-8.
4
Expression of mesothelin in thymic carcinoma and its potential therapeutic significance.间皮素在胸腺癌中的表达及其潜在治疗意义。
Lung Cancer. 2016 Nov;101:104-110. doi: 10.1016/j.lungcan.2016.09.015. Epub 2016 Sep 28.
5
Thymoma and thymic carcinomas.胸腺瘤和胸腺癌。
Crit Rev Oncol Hematol. 2016 Mar;99:332-50. doi: 10.1016/j.critrevonc.2016.01.012. Epub 2016 Jan 19.
6
Immune-related adverse events with immune checkpoint blockade: a comprehensive review.免疫检查点阻断相关的免疫相关不良事件：一项全面综述。
Eur J Cancer. 2016 Feb;54:139-148. doi: 10.1016/j.ejca.2015.11.016. Epub 2016 Jan 5.
7
Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.胸腺上皮肿瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2015 Sep;26 Suppl 5:v40-55. doi: 10.1093/annonc/mdv277.
8
Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy.古斯塔夫·鲁西研究所早期临床药物研发项目（I期试验）中入组的晚期胸腺恶性肿瘤患者的抗肿瘤活性。
Lung Cancer. 2015 Sep;89(3):306-10. doi: 10.1016/j.lungcan.2015.06.014. Epub 2015 Jun 22.
9
The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment.免疫检查点抑制剂在癌症治疗中不断演变的作用。
Oncologist. 2015 Jul;20(7):812-22. doi: 10.1634/theoncologist.2014-0422. Epub 2015 Jun 11.
10
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.舒尼替尼治疗化疗难治性胸腺瘤和胸腺癌患者：一项开放标签的2期试验。
Lancet Oncol. 2015 Feb;16(2):177-86. doi: 10.1016/S1470-2045(14)71181-7. Epub 2015 Jan 13.